Prion protein expression and release by mast cells after activation

Journal of Infectious Diseases

Volumn 200, Issue 5, 2009, Pages 827-831

  James Haddon, D ^a   Hughes, Michael R ^a   Antignano, Frann ^b   Westaway, David ^e   Cashman, Neil R ^c,d   McNagny, Kelly M ^a  

^a The Biomedical Research Centre   (Canada)

^b BRITISH COLUMBIA CANCER AGENCY   (Canada)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; BIOLOGICAL MARKER; PRNP PROTEIN, MOUSE;

ALLERGY; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HEMATOPOIETIC STEM CELL; INFLAMMATION; MAST CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; COMPARATIVE STUDY; GENE EXPRESSION PROFILING; HUMAN; METABOLISM; PRION;

ANIMALS; BIOLOGICAL MARKERS; GENE EXPRESSION PROFILING; HEMATOPOIETIC STEM CELLS; HUMANS; MAST CELLS; MICE; MICE, INBRED C57BL; PRIONS;

EID: 70349315357     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/605022     Document Type: Article

References (15)

1. Drew E, Merkens H, Chelliah S, Doyonnas R, McNagny KM. CD34 is a specific marker of mature murine mast cells. Exp Hematol 2002;30: 1211.
2. 2. Cashman NR, Loertscher R, Nalbantoglu J, et al. Cellular isoform of the scrapie agent protein participates in lymphocyte activation. Cell 1990;61:185-192 (Pubitemid 20134389)
3. 3. Dodelet VC, Cashman NR. Prion protein expression in human leukocyte differentiation. Blood 1998;91:1556-1561 (Pubitemid 28110319)
4. Bueler H, Fischer M, Lang Y, et al. Normal development and behaviour of mice lacking the neuronal cell-surface PrP protein. Nature 1992; 356:577-582
5. 5. Perez-Iratxeta C, Palidwor G, Porter CJ, et al. Study of stem cell function using microarray experiments. FEBS Lett 2005;579:1795-1801 (Pubitemid 40342656)
6. 6. Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res 2002;30:207-210 (Pubitemid 34679544)
7. 7. Hartmann K, Henz BM, Kruger-Krasagakes S, et al. C3a and C5a stimulate Chemotaxis of human mast cells. Blood 1997; 89:2863-2870 (Pubitemid 27172573)
8. 8. Nishizumi H, Yamamoto T. Impaired tyrosine phosphorylation and Ca2+ mobilization, but not degranulation, in lyn-deficient bone marrow-derived mast cells. J Immunol 1997; 158:2350-2355 (Pubitemid 127470021)
9. 9. Zhang CC, Steele AD, Lindquist S, Lodish HF. Prion protein is expressed on long-term repopulating hematopoietic stem cells and is important for their self-renewal. Proc Natl Acad Sei U S A 2006; 103: 2184-2189 (Pubitemid 43271644)
10. 10. Fevrier B, Vilette D, Archer F, et al. Cells release prions in association with exosomes. Proc Natl Acad Sei U S A 2004; 101:9683-9688 (Pubitemid 38869296)
11. Alais S, Simoes S, Baas D, et al. Mouse neuroblastoma cells release prion infectivity associated with exosomal vesicles. Biol Cell 2008; 100: 603-615
12. 12. Parkin ET, Watt NT, Turner AJ, Hooper NM. Dual mechanisms for shedding of the cellular prion protein. J Biol Chem 2004; 279:11170-11178 (Pubitemid 38401611)
13. 13. McMahon HE, Mange A, Nishida N, Creminon C, Casanova D, Lehmann S. Cleavage of the amino terminus of the prion protein by reactive oxygen species. J Biol Chem 2001;276:2286-2291 (Pubitemid 32109714)
14. 14. Vincent B, Paitel E, Saftig P, et al. The disintegrins ADAM10 and TACE contribute to the constitutive and phorbol ester-regulated normal cleavage of the cellular prion protein. J Biol Chem 2001;276:37743-37746 (Pubitemid 37384016)
15. 15. Zhou JS, Xing W, Friend DS, Austen KF, Katz HR. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J Exp Med 2007;204:2797-2802 (Pubitemid 350179550)